Descargar PDF

Otros usuarios también vieron estos artículos

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study Mireia Moreno, Marta Arévalo, Marc Zamora, Caridad Pontes, Juan Carlos Oliva, Jordi Gratacós
10.1016/j.reuma.2019.07.005
Changes in immature granulocyte levels and their association with disease activation following biologic therapy in patients with ankylosing spondylitis Burak Okyar, Servet Yüce, İbrahim Halil Bilen, Bekir Torun, İlyas Öztürk, Gözde Yıldırım Çetin
10.1016/j.reuma.2024.09.006
ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy Nathan Vastesaeger, Bert Vander Cruyssen, Juan Mulero, Jordi Gratacós Masmitjá, Pedro Zarco, Raquel Almodovar, Pilar Font, Xavier Juanola, Eduardo Collantes-Estevez
10.1016/j.reuma.2013.12.006